(VSAR) - Earnings & Price History

VSAR: - 1.775, $64.93M, -0.03 (-1.39%)

Sector: Healthcare - Industry: Drugs - Generic

Versartis, Inc. operates as an endocrine-focused biopharmaceutical company in the United States. The company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase 3 clinical trials for the treatment of growth hormone deficiency. It develops drug candidates that it has licensed from Amunix Operating, Inc. The company was founded in 2008 and is headquartered in Menlo Park, California.Key Statistics

Past VSAR reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-21AMC-0.6219.518.9519.5518.3519.883.17%-0.26%2.90%501.09K
2017-02-17AMC-0.62
2017-02-16AMC-0.6216.3515.715.715.5516.454.14%4.14%89.42K
2016-10-28AMC-0.26
2016-10-27AMC-0.2612.2511.8511.9511.812.30.84%2.51%3.38%342.00K
2016-02-12AMC-0.71
2016-02-11AMC-0.718.187.978.287.878.433.89%-1.21%2.63%186.39K
2016-02-10AMC-0.717.978.658.477.768.65-2.08%-5.90%-7.86%284.64K
2015-08-04BMO-0.6418.6818.118.0417.4819.24-0.33%3.55%3.20%186.24K
2015-08-03AMC-0.6418.6818.118.0417.4819.24-0.33%3.55%3.20%186.24K
2015-05-06AMC-0.6315.4617.2915.41516.46-10.93%▲0.39%-10.58%1.03M
2015-05-05AMC-0.6317.2917.2217.3116.8917.530.52%▲-0.12%0.41%43.61K
2015-05-04AMC-0.6317.2217.3117.3116.8717.76-0.52%-0.52%85.11K
2014-11-06AMCVersartis Inc-0.5719.4819.341817.5719.77-6.93%8.22%0.72%42.10K

Login | Register
Saturday May 26, 2018   EST
Enter a Ticker:

Economic Calendar

Durable Goods Orders 8:30 AM ET Consumer Sentiment 10:00 AM ET Charles Evans Speaks 11:45 AM ET Raphael Bostic Speaks 11:45 AM ET Robert Kaplan Speaks 11:45 AM ET Baker-Hughes Rig Count 1:00 PM ET SIFMA Rec. Early Close 2:00 ET  

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades